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Primary  chylopericardium
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mPericardial  ﬂuid  is  created  from  an  epicardial  and  parietal
pericardial capillary  ultraﬁltrate  with  contributions  from
myocardial interstitial  liquid  that  crosses  the  epicardium
[1]. Drainage  of  pericardial  ﬂuid  occurs  largely  through  a
complex network  of  lymphatic  vessels  [2].  Thus,  the  net-
work of  lymphatic  vessels  is  also  important  for  pericardial
ﬂuid accumulation.
Chylopericardium is  an  accumulation  of  chylous  ﬂuid  in
the pericardial  cavity.  It  occurs  generally  after  chest  trauma
(blunt or  penetrating),  or  thoracic  and  cardiac  surgery.
Episodes of  vomiting  or  violent  coughing,  which  may  be
related to  blunt  trauma,  can  induce  chylopericardium.  It
may also  occur  as  a  result  of  mediastinal  neoplasms,  medi-
astinal tuberculosis,  mediastinal  radiotherapy,  ﬁlariasis,
thrombosis of  the  subclavian  vein,  or  congenital  lymphang-
iectasis [3—7].
Primary or  idiopathic  chylopericardium  is  a  diagnosis  in
the absence  of  any  apparent  precipitating  factor.  Idiopathic
chylopericardium was  ﬁrst  reported  in  1888  by  Hasebrock
[8]. The  term  primary  isolated  chylopericardium  was  ﬁrst
reported by  Groves  and  Efﬂer  in  1954  [9].  Since  then,  around
120 cases  have  been  reported  from  all  around  the  world.  It
occurs in  all  ages  and  affects  both  sexes  equally,  although
most cases  present  in  children  and  young  adults  [10].
Hattori  et  al.  [11]  reported  two  young  female  cases  of
chylopericardium with  primary  chylopericardium,  and  both
cases were  asymptomatic.  Although  the  majority  of  cases
are asymptomatic,  clinical  manifestations  may  vary;  dysp-
nea, fatigue  and  cough  are  common,  while  tamponade  is
rare [10,12].
Chylopericardium is  usually  diagnosed  by  pericardio-
centesis showing  the  presence  of  chylous  ﬂuid  with  high
triglyceride level,  as  Hattori  et  al.  [11]  showed.
Primary  chylopericardium  results  from  retrograde  ﬂow
through abnormal  lymphatics  into  a  rich  pericardial  plexus.
Although the  underlying  pathophysiology  of  primary  chy-
lopericardium remains  unknown,  several  mechanisms  have
been proposed  to  explain  the  development  of  chyloperi-
cardium, including:  obstruction  of  the  thoracic  duct;  failure
to establish  collateral  drainage  to  the  right  thoracic
duct; reﬂux  of  chylous  lymph  through  normal  lymphatic
channels that  drain  the  pericardium  and  heart;  and
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Because normal  lymphatic  valves  prevent  chylous  reﬂux
nto the  pericardial  plexus,  blunt  chest  trauma  may  also
nduce chylopericardium  by  inducing  an  elevated  intratho-
acic pressure  that  ruptures  lymphatic  valves  [13].  Moreover,
ymphatic hypertension  and  increased  permeability  of  lym-
hatics may  be  alternative  mechanisms  that  could  explain
he pathogenesis  of  chylopericardium  [14].
Many  diagnostic  modalities  have  been  described:  obser-
ation of  Sudan  III  dye  distribution  into  the  pericardial  cavity
fter oral  intake  of  Sudan  III  dye;  lymphangioscintigraphy;
ymphangiography;  computed  tomography  lymphangiogra-
hy; and  evaluation  of  chest  radioactivity  after  oral
dministration of 131I-triolein  or 123I-beta-methyl  iodophenyl
entadecanoic acid  (123I-BMIPP,  i.e.,  lymphoscintigraphy)
15—17].
Lymphoscintigraphy is  faster  and  less  invasive  than  lym-
hangiography. Hattori  et  al.  [11]  performed 123I-BMIPP
ymphoscintigraphy  in  two  cases  for  diagnosis,  and  it  was
seful for  detecting  abnormal  accumulation  in  both  cases
efore the  operation.  Thus,  lymphoscintigraphy  seems  to
e one  of  the  convenient  examinations  for  the  diagnosis  of
hylopericardium.
Lymphangiography may  establish  ﬁstulous  connections
nd is  also  useful  for  delineating  the  anatomy  of  the  thoracic
uct [18—20].  Previous  reports  actually  demonstrated  that
ymphangiography combined  with  computed  tomography  or
ntraoperative thoracic  ductography  identiﬁed  the  locations
f the  lymphatic  leaks  and  ﬁstulas  [18—20].
Hattori  et  al.  [11]  also  performed  intraoperative  thoracic
uct angiography  to  identify  the  thoracic  duct  and  con-
rm abnormal  communication  between  the  thoracic  duct
nd pericardium  with  or  without  thoracic  duct  obstruc-
ion. Drainage  and  dietary  manipulation  is  an  effective
herapy in  approximately  55%  of  cases  [12].  Surgical  treat-
ent is  required  when  failure  to  respond  to  a diet  rich  in
edium-chain triglycerides  and  pericardiocentesis  occurs.nformation provided  by  lymphangiography  is  important  for
urgery.
Surgical treatment  consists  of  ligation  and  excision  of  the
horacic duct  and  partial  pericardiectomy.  Thoracic  duct
Published by Elsevier Ltd. All rights reserved.
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igation  has  to  be  performed  just  above  the  diaphragm
ecause the  anatomy  of  the  thoracic  duct  may  vary,  and
n approximately  25%  of  cases,  multiple  ducts  are  present
t the  level  above  the  diaphragm  [18].  Pericardiectomy
s performed  to  ensure  complete  drainage  and  to  prevent
ater constrictive  pericarditis.  This  procedure  has  also  been
erformed by  video-assisted  thoracoscopy  (VATS)  [21—23].
attori et  al.  [11]  treated  one  patient  with  primary  chy-
opericardium with  VATS.  They  performed  ligation  of  the
horacic duct,  and  a  partial  pericardiectomy  successfully  in
 patient  with  thoracotomy  because  they  were  unable  to
dentify thoracic  duct  by  VATS.
The  type  of  surgical  procedure  used,  VATS  versus  open
horacotomy, should  be  decided  on  a  patient-to-patient
asis and  should  be  chosen  according  to  each  situation
y responsible  surgeons.  Percutaneous  catheterization  and
mbolization of  the  thoracic  duct  have  been  reported  for
reatment of  chylothorax  and  chylopericardium  [24].  Fur-
her trials  are  needed  to  elucidate  the  effectiveness  of  this
herapy.
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